Laura Brege
CIK 1365619 · Lihat di SEC EDGAR ↗
Orang Dalam
Pengajuan SEC Pertama: 25 Maret 2021 · Terbaru: 12 Juni 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
Orang Dalam di
Transaksi orang dalam
0 beli (P)
0 jual (S)
Bersih:
$0
+ 83 transaksi non-pasar di bawah
12 bulan terakhir, berdasarkan transaksi yang ditunjukkan di bawah ini
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
83 pengajuan lain disembunyikan
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 16 Agu 2024 | PCRX | P | 1.000 | $12,81 | $12.810 | 17.552 Langsung | +6,04% | Diakuisisi | 88,0% (harga per 2026-08-20) |
| 12 Juni 2023 | ACAD | S 10b5-1 | 4.500 | $24,87 | $111.915 | 13.502 Langsung | -25,00% | Dilepas | 19,7% (harga per 2026-08-20) |
| 5 Juni 2023 | PCRX | S 10b5-1 | 600 | $38,74 | $23.244 | 9.547 Langsung | -5,91% | Dilepas | -37,8% (harga per 2026-08-20) |
| 3 April 2023 | PCRX | S 10b5-1 | 7.000 | $40,72 | $285.040 | 10.147 Langsung | -40,82% | Dilepas | -40,9% (harga per 2026-08-20) |
| 12 Jan. 2023 | ACAD | S 10b5-1 | 12.500 | $18,25 | $228.125 | 0 Langsung | -100,00% | Dilepas | 63,2% (harga per 2026-08-20) |
| 16 Nov. 2020 | PCRX | S | 12.000 | $65,95 | $791.400 | 7.921 Langsung | -60,24% | Dilepas | -63,5% (harga per 2026-08-20) |
| 5 Juni 2020 | PCRX | S | 2.100 | $48,70 | $102.270 | 6.661 Langsung | -23,97% | Dilepas | -50,5% (harga per 2026-08-20) |
| 7 Jan. 2020 | ACAD | S 10b5-1 | 10.000 | $42,19 | $421.900 | 0 Langsung | -100,00% | Dilepas | -29,4% (harga per 2026-08-20) |
| 10 Sep. 2019 | MIRM | P | 10.000 | $11,22 | $112.200 | 10.000 Langsung | — | Diakuisisi | 791,6% (harga per 2026-08-20) |
| 9 Jan. 2019 | ACAD | S 10b5-1 | 10.000 | $20,00 | $200.000 | 0 Langsung | -100,00% | Dilepas | 48,9% (harga per 2026-08-20) |
| 2 Jan. 2018 | ACAD | S 10b5-1 | 25.000 | $30,06 | $751.500 | 0 Langsung | -100,00% | Dilepas | -0,9% (harga per 2026-08-20) |
| 6 Juni 2016 | PCRX | S 10b5-1 | 1.000 | $46,95 | $46.950 | 1.000 Langsung | -50,00% | Dilepas | -48,7% (harga per 2026-08-20) |
| 11 Feb. 2015 | ACAD | S 10b5-1 | 10.000 | $33,63 | $336.300 | 0 Langsung | -100,00% | Dilepas | -11,4% (harga per 2026-08-20) |
| 15 Sep. 2014 | ACAD | S 10b5-1 | 10.000 | $28,07 | $280.700 | 0 Langsung | -100,00% | Dilepas | 6,1% (harga per 2026-08-20) |
| 9 Mei 2014 | PCRX | S 10b5-1 | 2.500 | $74,67 | $186.675 | 0 Langsung | -100,00% | Dilepas | -67,7% (harga per 2026-08-20) |
| 9 Mei 2014 | PCRX | S 10b5-1 | 7.500 | $73,57 | $551.775 | 2.500 Langsung | -75,00% | Dilepas | -67,3% (harga per 2026-08-20) |
| 4 April 2014 | ACAD | S 10b5-1 | 14.285 | $22,54 | $321.984 | 0 Langsung | -100,00% | Dilepas | 32,1% (harga per 2026-08-20) |
Menampilkan 100 dari 126 transaksi terakhir
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 15 Juni 2026 | MIRM | Deferred Stock Units | Common Stock (1.980) | — | — | 1.980 | Diakuisisi |
| 15 Juni 2026 | MIRM | Stock Option (right to buy) | Common Stock (3.772) | $101,00 | 14 Juni 2036 | 3.772 | Diakuisisi |
| 10 Juni 2026 | PCRX | Stock Option (Right to Buy) | Common Stock (10.891) | $23,42 | 10 Juni 2036 | 10.891 | Diakuisisi |
| 5 Juni 2026 | EWTX | Stock Option (Right to Buy) | Common Stock (16.377) | $35,59 | 5 Juni 2036 | 16.377 | Diakuisisi |
| 29 Mei 2026 | ACAD | Restricted Stock Units | Common Stock (9.311) | — | — | 9.311 | Diakuisisi |
| 29 Mei 2026 | ACAD | Director Stock Options (Right to Buy) | Common Stock (16.004) | $21,66 | 28 Mei 2036 | 16.004 | Diakuisisi |
| 29 Mei 2026 | ACAD | Restricted Stock Units | Common Stock (8.107) | — | — | 8.107 | Dilepas |
| 11 Juni 2025 | PCRX | Stock Option (Right to Buy) | Common Stock (11.279) | $24,34 | 11 Juni 2035 | 11.279 | Diakuisisi |
| 12 Juni 2024 | PCRX | Stock Option (Right to Buy) | Common Stock (12.179) | $28,68 | 12 Juni 2034 | 12.179 | Diakuisisi |
| 14 Juni 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (12.925) | $38,74 | 14 Juni 2033 | 12.925 | Diakuisisi |
| 12 Juni 2023 | MIRM | Stock Option (right to buy) | Common Stock (17.000) | $28,97 | 11 Juni 2033 | 17.000 | Diakuisisi |
| 1 Juni 2023 | ACAD | Restricted Stock Units | Common Stock (6.652) | — | — | 6.652 | Diakuisisi |
| 1 Juni 2023 | ACAD | Director Stock Options (Right to Buy) | Common Stock (11.045) | $23,90 | 31 Mei 2033 | 11.045 | Diakuisisi |
| 1 Juni 2023 | ACAD | Restricted Stock Units | Common Stock (8.552) | — | — | 8.552 | Dilepas |
| 3 April 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (7.000) | $29,90 | 12 Juni 2023 | 7.000 | Dilepas |
| 12 Jan. 2023 | ACAD | Stock Option (Right to Buy) | Common Stock (12.500) | $17,01 | 6 Juni 2023 | 12.500 | Dilepas |
| 8 Juni 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (8.225) | $59,39 | 8 Juni 2032 | 8.225 | Diakuisisi |
| 7 Juni 2022 | ACAD | Restricted Stock Units | Common Stock (6.391) | — | — | 6.391 | Dilepas |
| 7 Juni 2022 | ACAD | Restricted Stock Units | Common Stock (8.552) | — | — | 8.552 | Diakuisisi |
| 7 Juni 2022 | ACAD | Director Stock Options (Right to Buy) | Common Stock (14.368) | $18,27 | 6 Juni 2032 | 14.368 | Diakuisisi |
| 2 Juni 2022 | MIRM | Stock Option (right to buy) | Common Stock (17.000) | $23,51 | 1 Juni 2032 | 17.000 | Diakuisisi |
| 22 Juni 2021 | ACAD | Restricted Stock Units | Common Stock (3.059) | — | — | 3.059 | Dilepas |
| 22 Juni 2021 | ACAD | Director Stock Options (Right to Buy) | Common Stock (11.637) | $24,88 | 21 Juni 2031 | 11.637 | Diakuisisi |
| 22 Juni 2021 | ACAD | Restricted Stock Units | Common Stock (6.391) | — | — | 6.391 | Diakuisisi |
| 9 Juni 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (7.626) | $60,96 | 9 Juni 2031 | 7.626 | Diakuisisi |
| 4 Juni 2021 | MIRM | Stock Option (right to buy) | Common Stock (17.000) | $16,88 | 3 Juni 2031 | 17.000 | Diakuisisi |
| 16 Nov. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (12.000) | $13,98 | 2 Juni 2021 | 12.000 | Dilepas |
| 23 Juni 2020 | ACAD | Restricted Stock Units | Common Stock (3.059) | — | — | 3.059 | Diakuisisi |
| 23 Juni 2020 | ACAD | Director Stock Options (Right to Buy) | Common Stock (5.579) | $52,73 | 22 Juni 2030 | 5.579 | Diakuisisi |
| 11 Juni 2020 | MIRM | Stock Option (right to buy) | Common Stock (14.167) | $16,71 | 10 Juni 2030 | 14.167 | Diakuisisi |
| 9 Juni 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (8.027) | $47,65 | 9 Juni 2030 | 8.027 | Diakuisisi |
| 7 Jan. 2020 | ACAD | Stock Option (Right to Buy) | Common Stock (10.000) | $1,75 | 9 Juni 2021 | 10.000 | Dilepas |
| 17 Juli 2019 | MIRM | Stock Option (right to buy) | Common Stock (17.000) | $15,00 | 16 Juli 2029 | 17.000 | Diakuisisi |
| 26 Juni 2019 | ACAD | Stock Option (Right to Buy) | Common Stock (15.000) | $25,24 | 26 Juni 2029 | 15.000 | Dilepas |
| 5 Juni 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (8.437) | $43,54 | 5 Juni 2029 | 8.437 | Diakuisisi |
| 9 Jan. 2019 | ACAD | Stock Option (Right to Buy) | Common Stock (10.000) | $2,16 | 11 Juni 2019 | 10.000 | Dilepas |
| 13 Juni 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (4.693) | $38,35 | 13 Juni 2028 | 4.693 | Diakuisisi |
| 6 Juni 2018 | ACAD | Stock option (right to buy) | Common Stock (15.000) | $17,52 | 5 Juni 2028 | 15.000 | Diakuisisi |
| 2 Jan. 2018 | ACAD | Stock option (right to buy) | Common Stock (15.000) | $8,06 | 30 April 2018 | 15.000 | Dilepas |
| 2 Jan. 2018 | ACAD | Stock option (right to buy) | Common Stock (10.000) | $8,49 | 12 Juni 2018 | 10.000 | Dilepas |
| 14 Juni 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (2.714) | $44,20 | 14 Juni 2027 | 2.714 | Diakuisisi |
| 13 Juni 2017 | ACAD | Stock Option (right to buy) | Common Stock (15.000) | $27,25 | 12 Juni 2027 | 15.000 | Diakuisisi |
| 15 Juni 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (2.975) | $40,34 | 15 Juni 2026 | 2.975 | Diakuisisi |
| 10 Juni 2016 | ACAD | Stock option (right to buy) | Common Stock (12.500) | $39,60 | 9 Juni 2026 | 12.500 | Diakuisisi |
| 15 Juni 2015 | ACAD | Stock option (right to buy) | Common Stock (12.500) | $39,06 | 14 Juni 2025 | 12.500 | Diakuisisi |
| 3 Juni 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (4.000) | $79,43 | 3 Juni 2025 | 4.000 | Diakuisisi |
| 11 Feb. 2015 | ACAD | Stock option (right to buy) | Common Stock (10.000) | $1,75 | 9 Juni 2021 | 10.000 | Dilepas |
| 15 Sep. 2014 | ACAD | Stock option (right to buy) | Common Stock (10.000) | $1,75 | 9 Juni 2021 | 10.000 | Dilepas |
| 6 Juni 2014 | ACAD | Stock option (right to buy) | Common Stock (12.500) | $21,99 | 5 Juni 2024 | 12.500 | Diakuisisi |
| 3 Juni 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (8.000) | $81,00 | 3 Juni 2024 | 8.000 | Diakuisisi |
| 9 Mei 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (3.000) | $13,98 | 2 Juni 2021 | 3.000 | Dilepas |
| 9 Mei 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (7.000) | $10,81 | 4 Juni 2022 | 7.000 | Dilepas |
| 4 April 2014 | ACAD | Stock option (right to buy) | Common Stock (14.285) | $1,75 | 9 Juni 2021 | 14.285 | Dilepas |
| 15 Jan. 2014 | ACAD | Stock option (right to buy) | Common stock (10.000) | $1,36 | 7 Juni 2022 | 10.000 | Dilepas |
| 10 Des. 2013 | ACAD | Stock option (right to buy) | Common stock (44.117) | $1,36 | 7 Juni 2022 | 44.117 | Dilepas |
| 10 Okt. 2013 | ACAD | Stock option (right to buy) | Common stock (10.000) | $1,30 | 10 Juni 2020 | 10.000 | Dilepas |
| 10 Sep. 2013 | ACAD | Stock option (right to buy) | Common stock (46.153) | $1,30 | 10 Juni 2020 | 46.153 | Dilepas |
| 12 Juni 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (7.000) | $29,20 | 11 Juni 2023 | 7.000 | Diakuisisi |
| 7 Juni 2013 | ACAD | Stock option (right to buy) | Common stock (12.500) | $17,01 | 6 Juni 2023 | 12.500 | Diakuisisi |
| 6 Juli 2012 | DCTH | Stock Option (right to buy) | Common Stock (54.586) | $2,00 | 6 Juli 2022 | 54.586 | Diakuisisi |
| 8 Juni 2012 | ACAD | Stock option (right to buy) | Common stock (10.000) | $1,36 | 7 Juni 2022 | 10.000 | Diakuisisi |
| 8 Juni 2012 | ACAD | Stock option (right to buy) | Common stock (44.117) | $1,36 | 7 Juni 2022 | 44.117 | Diakuisisi |
| 5 Juni 2012 | PCRX | Common Stock | Common Stock (7.000) | $10,81 | 4 Juni 2022 | 7.000 | Diakuisisi |
| 10 Juni 2011 | ACAD | Stock option (right to buy) | Common stock (10.000) | $1,75 | 9 Juni 2021 | 10.000 | Diakuisisi |
| 10 Juni 2011 | ACAD | Stock option (right to buy) | Common stock (34.285) | $1,75 | 9 Juni 2021 | 34.285 | Diakuisisi |
| 2 Juni 2011 | PCRX | Stock option (right to buy) | Common Stock (15.000) | $13,98 | 2 Juni 2021 | 15.000 | Diakuisisi |
| 11 Juni 2010 | ACAD | Stock option (right to bou) | Common Stock (46.153) | $1,30 | 10 Juni 2020 | 46.153 | Diakuisisi |
| 11 Juni 2010 | ACAD | Stock option (right to buy) | Common stock (10.000) | $1,30 | 10 Juni 2020 | 10.000 | Diakuisisi |
| 12 Juni 2009 | ACAD | Stock Option (right to buy) | Common Stock (10.000) | $2,16 | 11 Juni 2019 | 10.000 | Diakuisisi |
| 13 Juni 2008 | ACAD | Stock Option (right to buy) | Common Stock (10.000) | $8,49 | 12 Juni 2018 | 10.000 | Diakuisisi |
| 1 Mei 2008 | ACAD | Option (right to buy) | Common Stock (15.000) | $8,06 | 30 April 2018 | 15.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 3 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.